SIGA Technologies, Inc. (SIGA) Research

SIGA Technologies, Inc. is a pharmaceutical company with commercialized products, specializing in the health security and infectious disease sectors across the United States. A core offering is TPOXX, an oral antiviral drug formulated to combat human smallpox, a condition caused by the variola virus. Furthermore, the company has forged a strategic collaboration with Cipla Therapeutics. This partnership aims to ensure ongoing innovation and accessibility of antibacterial treatments, particularly those designed to counter biothreats. Founded in 1995, SIGA Technologies' corporate headquarters are located in New York, New York.

Market snapshot

Symbol
SIGA
Price
$4.32
Day change
+0.23%
Market cap
$309.8M
P/E ratio
15.28x
52-week range
4.1-9.62
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Next earnings
in 2 months

Recent news

  • Why Are Siga Technologies Shares Trading Higher?

    Siga's board of directors declared a special cash dividend of $0.60 per share on the company's common stock. The amount of this dividend is consistent with the special dividend declared last April.

Peer companies

  • Aquestive Therapeutics, Inc. (AQST)
  • CytomX Therapeutics, Inc. (CTMX)
  • DarioHealth Corp. (DRIO)
  • Emergent BioSolutions Inc. (EBS)
  • Esperion Therapeutics, Inc. (ESPR)
  • Olema Pharmaceuticals, Inc. (OLMA)
  • Organogenesis Holdings Inc. (ORGO)
  • Rigel Pharmaceuticals, Inc. (RIGL)

Recent insider activity

  • Marshall Joseph W III — M-Exempt (24116 shares) on 2026-06-09
  • Marshall Joseph W III — D-Return (7235 shares) on 2026-06-09
  • Marshall Joseph W III — A-Award (34169 shares) on 2026-06-09
  • Marshall Joseph W III — M-Exempt (24116 shares) on 2026-06-09
  • KEANE JOHN M — A-Award (34169 shares) on 2026-06-09

Open SIGA Technologies, Inc. (SIGA) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.